Back
Sangamo Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
SGMO
Sangamo Therapeutics
Last Price:
1.95
Seasonality Move:
29.11%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- The current trend is moderately bearish and SGMO is experiencing slight buying pressure.
Sangamo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Sell |
| 20-day SMA: | 2.15 | Sell |
| 50-day SMA: | 1.41 | Buy |
| 200-day SMA: | 0.86 | Buy |
| 8-day EMA: | 2.08 | Sell |
| 20-day EMA: | 2.01 | Sell |
| 50-day EMA: | 1.59 | Buy |
| 200-day EMA: | 1.05 | Buy |
Sangamo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 51.9 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.44 - 2.48) | Sell |
| Bollinger Bands (100): | (0.45 - 1.67) | Buy |
Sangamo Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
- Sangamo Therapeutics share price is 1.96 while SGMO 8-day simple moving average is 2.14, which is a Sell signal.
- The stock price of SGMO is 1.96 while Sangamo Therapeutics 20-day SMA is 2.15, which makes it a Sell.
- Sangamo Therapeutics 50-day simple moving average is 1.41 while SGMO share price is 1.96, making it a Buy technically.
- SGMO stock price is 1.96 and Sangamo Therapeutics 200-day simple moving average is 0.86, creating a Buy signal.
SGMO Technical Analysis vs Fundamental Analysis
Sell
49
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a Sell
The current Sangamo Therapeutics [SGMO] share price is $1.96. The Score for SGMO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
408.95M
Price in USD:
1.96
Share Volume:
3.29M
Sangamo Therapeutics 52-Week Range
52-Week High:
3.18
52-Week Low:
0.30
Sell
49
Sangamo Therapeutics (SGMO)
is a Sell
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?
The Sangamo Therapeutics stock price is 1.96 USD today. -
Will SGMO stock go up or go down?
Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sangamo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is overvalued.
Is Sangamo Therapeutics Stock a Buy?
- Sangamo Therapeutics share price is 1.96 while SGMO 8-day exponential moving average is 2.08, which is a Sell signal.
- The stock price of SGMO is 1.96 while Sangamo Therapeutics 20-day EMA is 2.01, which makes it a Sell.
- Sangamo Therapeutics 50-day exponential moving average is 1.59 while SGMO share price is 1.96, making it a Buy technically.
- SGMO stock price is 1.96 and Sangamo Therapeutics 200-day simple moving average is 1.05, creating a Buy signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.32 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
- SGMO Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Sangamo Therapeutics is a Buy
- Sangamo Therapeutics Relative Strength Index (RSI) is 51.9, which suggest Sangamo Therapeutics is overbought
- The Bollinger Bands (25) for Sangamo Therapeutics is (1.44 - 2.48), which suggest Sangamo Therapeutics is a Buy
- The Bollinger Bands (100) for Sangamo Therapeutics is (0.45 - 1.67), which suggest Sangamo Therapeutics is a Buy
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.